New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics?

Abstract excerpt

For patients requiring long-term anticoagulation, oral vitamin K antagonists (VKAs) such as warfarin have overwhelming efficacy data and present significant challenges. In addition to the potential exposure to numerous drug-drug and drug-food interactions, patients receiving warfarin require frequent monitoring. It had been hoped that the integration of pharmacogenomic with clinical information would improve...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antithrombins
• Share to Atrial Fibrillation
• Share to Benzimidazoles